Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients

Clinical trial NCT00158782 · COMPLETED

Trial details

NCT number: NCT00158782
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2004-09-28
Primary completion: 2007-08-21
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.